Wall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a Bet

Impact · against what's priced in

The analyst consensus for Globus Medical provides no new catalyst, as the current price already reflects a deep discount to those targets. The market is explicitly rejecting the bullish targets cited in the article, treating them as declined scenarios rather than imminent price drivers.

GMED+0.00: Already priced in
The price assumes: The price sits at the very bottom of the published model range, rejecting all four bull cases to trade 23% below the median target

Wall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a Bet

What matters in this story

How Much Upside is Left in Tarsus Pharmaceuticals (TARS)? Wall Street Analysts Think 30.78%

Wall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a Bet

What matters in this story

How Much Upside is Left in Tarsus Pharmaceuticals (TARS)? Wall Street Analysts Think 30.78%

How each ticker is affected

Track these names every morning.

How Much Upside is Left in Vista Energy, S.A.B. de C.V. - Sponsored ADR (VIST)?

Does AudioEye (AEYE) Have the Potential to Rally 33% as Wall Street Analysts Expect?

Wall Street Analysts See a 25.99% Upside in Blue Owl Capital Corporation (OBDC): Can the Stock Really Move This High?

First-in-Human Coronary Intervention Study Results of Robocath's Next-Generation Robotic System Highlighted at TCT

Wall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a Bet

What matters in this story

Next reads from the same story arc

How Much Upside is Left in Tarsus Pharmaceuticals (TARS)? Wall Street Analysts Think 30.78%

Wall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a Bet

What matters in this story

Next reads from the same story arc

How Much Upside is Left in Tarsus Pharmaceuticals (TARS)? Wall Street Analysts Think 30.78%

How each ticker is affected

Track these names every morning.

How Much Upside is Left in Vista Energy, S.A.B. de C.V. - Sponsored ADR (VIST)?

Does AudioEye (AEYE) Have the Potential to Rally 33% as Wall Street Analysts Expect?

Wall Street Analysts See a 25.99% Upside in Blue Owl Capital Corporation (OBDC): Can the Stock Really Move This High?

First-in-Human Coronary Intervention Study Results of Robocath's Next-Generation Robotic System Highlighted at TCT